Fourth Sail Capital LP grew its stake in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 61.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,171,102 shares of the company's stock after buying an additional 1,209,277 shares during the period. Bioceres Crop Solutions accounts for approximately 6.3% of Fourth Sail Capital LP's holdings, making the stock its 5th biggest holding. Fourth Sail Capital LP owned approximately 5.05% of Bioceres Crop Solutions worth $24,957,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of BIOX. Oppenheimer & Co. Inc. bought a new position in Bioceres Crop Solutions during the 1st quarter worth $139,000. Lazard Asset Management LLC acquired a new stake in shares of Bioceres Crop Solutions during the 1st quarter valued at about $212,000. Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the second quarter worth $448,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions in the second quarter valued at approximately $472,000. Finally, Dimensional Fund Advisors LP grew its stake in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after acquiring an additional 5,341 shares during the last quarter. Hedge funds and other institutional investors own 17.68% of the company's stock.
Wall Street Analysts Forecast Growth
BIOX has been the subject of a number of recent research reports. Oppenheimer dropped their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research report on Monday, October 21st. Canaccord Genuity Group cut their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Roth Mkm decreased their target price on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th. Finally, Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $12.13.
Get Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Price Performance
Bioceres Crop Solutions stock traded down $0.09 during mid-day trading on Monday, hitting $6.08. The stock had a trading volume of 104,106 shares, compared to its average volume of 90,183. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37. The firm's 50 day moving average is $7.42 and its 200 day moving average is $9.69. Bioceres Crop Solutions Corp. has a one year low of $5.71 and a one year high of $14.05. The firm has a market capitalization of $382.12 million, a P/E ratio of 304.00 and a beta of 0.49.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). The business had revenue of $92.60 million for the quarter, compared to analysts' expectations of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter in the previous year, the firm earned ($0.07) EPS. On average, sell-side analysts forecast that Bioceres Crop Solutions Corp. will post 0.12 earnings per share for the current fiscal year.
Bioceres Crop Solutions Profile
(
Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
See Also
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.